Bronnen:
- Panaccione R, Colombel JF, Travis SPL, et al. Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial. Gut. 2019 Jul 8.
Bronnen:
jan 2020 | Hepatologie
okt 2019
jul 2024
sep 2023